Turkish Pharmaceutical Company May Secure Deal to Produce Russian Vaccines in One Month

MOSCOW (Sputnik) – Pharmaceutical company Turk Ilac & Serum Sanayi AS is in talks to produce Russia’s coronavirus vaccines — Sputnik Light and the shot developed by the Chumakov Institute — in Turkey, CEO Berat Battal told Sputnik.

“Our main target was the single-dose Sputnik Light vaccine and the third registered Russian vaccine developed by Russia’s state-run Chumakov Institute. We’ve agreed in principle on the production of these vaccines, and Russian partners and we are very happy about our ongoing negotiations”, Battal said.

According to the CEO, as soon as a production agreement is reached, the “emergency use registration process will start”.

The Turkish company is expecting the negotiations to progress fast, the CEO said.

In August 2020, the Russian Health Ministry was the first regulatory authority in the world to register a coronavirus vaccine. Developed by the Gamaleya research centre, the two-dose shot was named Sputnik V. Russia has since registered three more vaccines, including Sputnik Light — a single-dose spinoff of Sputnik V — as well as a vaccine by the Chumakov Institute and the Russian research centre Vector’s EpiVacCorona.

Sourse: sputniknews.com